🇺🇸 FDA
Patent

US 9920109

Serpin fusion polypeptides and methods of purification thereof

granted A61KA61K38/00A61P

Quick answer

US patent 9920109 (Serpin fusion polypeptides and methods of purification thereof) held by Inhibrx, Inc. expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/04